Prices are updated after-hours

Professional, Scientific, and Technical Services 2022 - 04 - 15

NEXT-ChemX Corporation.

CHMX 4 | $4.5 0% 100

(0.0% 1d) (0.0% 1m) (-55.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-27.54% volume)
Earnings Calendar:
Market Cap: $ 128,460,753

Sec Filling | Patents | n/a employees

(US)

add to watch list Paper trade email alert is off

EARTH LIFE SCIENCES INC

CLTS | $0.0004 1525.0% 11K

Professional, Scientific, and T...

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-57.94% volume)
Earnings Calendar:
Market Cap: $ 399,957

Sec Filling | Patents | 1 employees

(CA)

add to watch list Paper trade email alert is off

Rennova Health, Inc.

RNVA | $0.0001 0.0% 23M

Professional, Scientific, and T...

(0.0% 1d) (-99.0% 1m) (-99.0% 1y) (0.0% 2d) (0.0% 3d) (-99.0% 7d) (-23.24% volume)
Earnings Calendar:
Market Cap: $ 4,055,132
https://www.rennovahealth.com/
Sec Filling | Patents | 78 employees

(US) we put the needs of healthcare providers at the center of everything we do. we understand the unprecedented challenges faced by providers today. we have made it our mission to create single-source solutions that help you navigate today’s turbulent regulatory, medical and market environments while protecting your patients, your employees and your profitability. our unified approach is driving new ideas rennova health is reimagining the traditional channels of healthcare services with an expansive suite of diverse products and brands. these interoperable solutions work in unison to drive better treatment outcomes, more cost-effective patient care, and optimized revenue streams. we support each of our solutions with unprecedented service excellence, while continuing to build on the best medical science and technologies available. we also maintain the highest standards of corporate transparency, fiduciary responsibility, accountability, and regulatory compliance. rennova health encompasses

profitable

add to watch list Paper trade email alert is off

QUANTA INC

QNTA | $0.0001 31K

Professional, Scientific, and T...

(0.0% 1d) (0.0% 1m) (-50.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (244.44% volume)
Earnings Calendar:
Market Cap: $ 50,563
http://www.quanta-inc.com/
Sec Filling | Patents | 10 employees

(US)

add to watch list Paper trade email alert is off

Werewolf Therapeutics Inc

HOWL | $5.6 2.0% 1.96% 430K

Professional, Scientific, and T...

(0.0% 1d) (-8.8% 1m) (120.5% 1y) (0.0% 2d) (0.0% 3d) (3.8% 7d) (-36.7% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 242,745,233
https://werewolftx.com
Sec Filling | Patents | n/a employees

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is leveraging its proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Its most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors.The company is continuing preclinical studies for both WTX-124 and WTX-330 and expect to advance each candidate in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor.

cancer immunotherapy msa treatment

add to watch list Paper trade email alert is off

Nukkleus Inc.

NUKK | $0.8098 -6.24% 110K

Professional, Scientific, and T...

(0.0% 1d) (-6.6% 1m) (1950.1% 1y) (0.0% 2d) (0.0% 3d) (-12.0% 7d) (-21.59% volume)
Earnings Calendar:
Market Cap: $ 0
https://www.nukk.com/
Sec Filling | Patents | 1 employees

(US) nukkleus, inc. (otc: nukk) is a fintech group that acquires, builds and scales blockchain and digital financial services businesses. the portfolio serves b2b and institutional clients with the aim of disrupting the banking & investment industry for the better.

add to watch list Paper trade email alert is off

Pyxis Oncology Inc

PYXS | $4.7 -0.84% -0.85% 260K

Professional, Scientific, and T...

(0.0% 1d) (-3.3% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (-6.7% 7d) (26.55% volume)
Earnings Calendar: 2023-11-01
Market Cap: $ 273,226,863
https://pyxisoncology.com
Sec Filling | Patents | 2021 employees

Pyxis Oncology, Inc. is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis develops its product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Since its launch in 2019, Pyxis has developed a broad portfolio of novel antibody drug conjugate, or ADC, product candidates, and monoclonal antibody, or mAb, preclinical discovery programs that it is developing as monotherapies and in combination with other therapies.

cancer t-cell

add to watch list Paper trade email alert is off

Synaptogenix Inc

SNPX | $4.7 6.34% 5.96% 93K

Professional, Scientific, and T...

(0.0% 1d) (2143.7% 1m) (407.5% 1y) (0.0% 2d) (0.0% 3d) (-6.0% 7d) (15.24% volume)
Earnings Calendar:
Market Cap: $ 127,526,740

Sec Filling | Patents | 5 employees

synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.

add to watch list Paper trade email alert is off

Vivakor, Inc.

VIVK | $0.8996 0.99% 28K

Professional, Scientific, and T...

(0.0% 1d) (5.8% 1m) (-19.0% 1y) (0.0% 2d) (0.0% 3d) (11.3% 7d) (-91.19% volume)
Earnings Calendar:
Market Cap: $ 23,587,969

Sec Filling | Patents | 25 employees

vivakor inc is a company based out of 2590 holiday rd ste 100, coralville, iowa, united states.

add to watch list Paper trade email alert is off

Connect Biopharma Holdings Ltd - ADR

CNTB | $1.7 1.8% 1.76% 110K

Professional, Scientific, and T...

(0.0% 1d) (34.7% 1m) (53.2% 1y) (0.0% 2d) (0.0% 3d) (-10.2% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 93,621,650
https://www.connectbiopharm.com
Sec Filling | Patents | 2021 employees

Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from its T cell-driven research. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα), which is a validated target for the treatment of several inflammatory diseases such as atopic dermatitis (AD) and asthma. Its second lead product candidate is CBP-307, a modulator of a T cell receptor known as sphingosine 1-phosphate receptor 1 (S1P1).

ceiling treatment brands antibody t-cell

add to watch list Paper trade email alert is off

ACORN ENERGY, INC.

ACFN | $7.2 -95.92% 230

Professional, Scientific, and T...

(0.0% 1d) (8.3% 1m) (2150.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (74.36% volume)
Earnings Calendar:
Market Cap: $ 17,908,610

Sec Filling | Patents | 23 employees

acorn energy, inc. is a holding company whose four portfolio companies help their customers achieve greater productivity, reliability, security, and efficiency—factors which can lead to greater profitability. us seismic systems supplies fiber optic sensing solutions to increase oil/gas production and lower costs. gridsense provides monitoring for all critical points along the electricity delivery system. omnimetrix remotely monitors emergency back-up power generation systems to increase their reliability. dsit provides security solutions from underwater threats to naval and marine based energy assets. for more information visit: http://www.acornenergy.com. this profile may include forward-looking statements, which are subject to risks and uncertainties. there is no assurance that acorn energy, inc. or its operating companies will continue to grow their respective businesses, or that any of them will meet the expectations or execute the initiatives described or referred to above. a comp

profitable eletrical energy

add to watch list Paper trade email alert is off

Cell Source, Inc.

CLCS | $0.3975 15.25% 13K

Professional, Scientific, and T...

(0.0% 1d) (29.3% 1m) (-6.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (57.73% volume)
Earnings Calendar:
Market Cap: $ 16,305,191

Sec Filling | Patents | 1 employees

marrow cell source , has been started with the aim to cater to patients who required a matched bone marrow sample. indian gene pool requires a bone marrow registry

t-cell

add to watch list Paper trade email alert is off

Value Exchange International, Inc.

VEII 4 | $0.061 238.89% 23K

Professional, Scientific, and T...

(0.0% 1d) (34.4% 1m) (28.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (282.64% volume)
Earnings Calendar:
Market Cap: $ 2,653,546

Sec Filling | Patents | 300 employees

processing over us$ 20 billion worth in annual payment transactions at over 30,000 point of sale terminals for over 120 merchants, vei is recognized as the number #1 cloud based customer relationship management (crm) software service provider in the asia-pacific (apac) region. we’ve worked with retailers like a.s. watson group, 7-eleven, walmart, robinsons retail group; and with top technology partners like fujitsu, retalix, tencent, asiapay and more, to make your shopping experience even better. vei can help you drive new revenues and monetize your network in new and profitable ways. as the industry leader in innovative and collaborative technology solutions, vei can help you drive new revenues and monetize your network in new and profitable ways. vei’s solutions, platforms, and technologies provide a scalable, standards-based intelligent architecture that enables you to integrate subscriber knowledge with network and application intelligence in real-time to offer an expanding portfol

profitable spac

add to watch list Paper trade email alert is off

MDwerks, Inc.

MDWK | $0.21 -60.0% 2.5K

Professional, Scientific, and T...

(0.0% 1d) (-7.5% 1m) (1135.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (150.0% volume)
Earnings Calendar:
Market Cap: $ 26,773,219

Sec Filling | Patents | 7 employees

learn about working at mdwerks. join linkedin today for free. see who you know at mdwerks, leverage your professional network, and get hired.

add to watch list Paper trade email alert is off

UNIQUE LOGISTICS INTERNATIONAL INC

UNQL | $0.0038 21.15% 83K

Professional, Scientific, and T...

(0.0% 1d) (-32.6% 1m) (-68.3% 1y) (0.0% 2d) (0.0% 3d) (3.8% 7d) (17.13% volume)
Earnings Calendar:
Market Cap: $ 3,036,739

Sec Filling | Patents | 1 employees

add to watch list Paper trade email alert is off